𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ribavirin treatment for chronic hepatitis D: a pilot study

✍ Scribed by A. Garripoli; V. DI Marco; R. Cozzolongo; C. Costa; A. Smedile; A. Fabiano; F. Bonino; M. Rizzetto; G. Verme; A. Craxi; F. Rosina

Book ID
114796899
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
465 KB
Volume
14
Category
Article
ISSN
0106-9543

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A pilot study of ribavirin therapy for c
A pilot study of ribavirin therapy for chronic hepatitis C
✍ Adrian M. di Bisceglie; Michiko Shindo; Tse-Ling Fong; Michael W. Fried; Mark G. πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 541 KB

Interferon-alpha therapy is of proven efficacy in chronic hepatitis C, but it is not universally effective and may be associated with intolerable side effects. Ribavirin is a nucleoside analog with a broad spectrum of antiviral action. We conducted an uncontrolled pilot study of ribavirin therapy in

Ribavirin treatment for chronic hepatiti
Ribavirin treatment for chronic hepatitis C
✍ Reichard, O.; Andersson, J.; Schvarcz, R.; Weiland, O. πŸ“‚ Article πŸ“… 1991 πŸ› The Lancet 🌐 English βš– 529 KB
Pilot study of ribavirin and interferon-
Pilot study of ribavirin and interferon-Ξ² for chronic hepatitis B
✍ Shinichi Kakumu; Kentaro Yoshioka; Takaji Wakita; Tetsuya Ishikawa; Masahiro Tak πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 586 KB

## YASUYUKI HIGASHI Ribavirin is a nucleoside analog that inhibits the replication of many DNA and RNA viruses. To evaluate the efficacy of oral ribavirin, we randomly assigned 24 HBeAg-positive patients with chronic active hepatitis to a 12-wk course of treatment with 0.8 to 1.0 gm/ribavirin day,